51 results
Page 2 of 3
S-3ASR
EX-4.1
pwr phe6fk1xljyp
7 Dec 20
Automatic shelf registration
4:15pm
S-8
EX-4.3
eux8l5kas
5 Aug 20
Registration of securities for employees
12:00am
424B5
4xdv9hmsyz 8qaq0pg
30 Jul 20
Prospectus supplement for primary offering
6:01am
8-K
EX-1.1
0qup3pf
29 Jul 20
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock
6:02am
424B5
216wroe09eujw 2v2m
28 Jul 20
Prospectus supplement for primary offering
4:17pm
8-K
EX-1.1
tf8c6299 3k1s
17 Apr 20
Entry into a Material Definitive Agreement
6:06am
8-K
EX-10.1
pbqtiddjf4pgfwmod
27 Mar 20
Entry into a Material Definitive Agreement
5:20pm
10-K
EX-10.1
7ctmaipgk6rm5 0q1
16 Mar 20
Annual report
11:09am
10-K
p72ygrr7r7 li6
16 Mar 20
Annual report
11:09am
DEF 14A
z0xx9x11n6o7hddefnlz
1 Oct 19
Definitive proxy
6:07am
8-K
EX-1.1
yz5 zs68l5p36kbz
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
8-K
EX-10.1
zydob8jv
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
8-K
r1oe97
23 Sep 19
Arcturus Therapeutics Announces Appointment of Dr. Edward Holmes M.D. andRe-Appointment of Andy Sassine to the Board of Directors
4:34pm
8-K
EX-99.1
gfhhhg0
23 Sep 19
Arcturus Therapeutics Announces Appointment of Dr. Edward Holmes M.D. andRe-Appointment of Andy Sassine to the Board of Directors
4:34pm
8-K
EX-10.1
2otgewom7g jvefjzkt
5 Aug 19
Arcturus Therapeutics Announces $2.3 Million Additional Registered Direct Offering of Common Stock
9:14am
8-K
EX-1.1
8efphyeesp
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm
8-K
EX-10.1
6jrao47sq4jewdl 49
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm